Outside the usual rangeFebruary 2021Maternal and child
Meghalaya: MCV1 doses per 100 BCG doses in February 2021 was 98.4 per 100 BCG doses, above the 3-year median of 33.6 for the same month (+193%).
What happened
- February 2021
- 98.4
- 3-year median
- 33.6
- Change
- +64.8
- Change, per cent
- +193%
Why it matters
The value is judged against the median of the same period in up to five earlier years, using a robust measure of spread. A breach means this period sits well outside what those years would lead you to expect.
For MCV1 doses per 100 BCG doses, higher is better. This movement is therefore assessed as an improvement.
Historical context
Same-period values: 2020 90.2, 2019 33.6, 2018 28.5. This comparison involves the COVID-19 disruption period (March 2020 – June 2021), when service use and reporting fell sharply.
The underlying data
| Period | Value | Release | Where in the document |
|---|---|---|---|
| February 2021 | 98.4 | HMIS item-wise monthly report, All India across states, February 2021 (FY 2020-21, provisional) | 2020-2021(Data is Provisional)/A.MonthWise/K-Feb.xlsx: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)/ Measles containing vaccine(MCV) - 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Meghalaya", Total [(A+B) or (C+D)] |
| February 2020 | 90.2 | HMIS item-wise monthly report, All India across states, February 2020 (FY 2019-20, provisional) | 2019-2020.zip › 2019-2020/A.MonthWise/K - February.xls: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)- 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Meghalaya", Total [(A+B) or (C+D)] |
| February 2019 | 33.6 | HMIS item-wise monthly report, All India across states, February 2019 (FY 2018-19, provisional) | 2018-2019.zip › 2018-2019/A.MonthWise/K - February.xls: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)- 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Meghalaya", Total [(A+B) or (C+D)] |
| February 2018 | 28.5 | HMIS item-wise monthly report, All India across states, February 2018 (FY 2017-18, provisional) | 2017-2018.zip › 2017-2018/A.MonthWise/K - February.xls: ('9.2.1' Child immunisation (9-11months) - Measles & Rubella (MR)- 1st Dose + '9.2.2' Child immunisation (9-11months) - Measles 1st dose) / ('9.1.2' Child immunisation - BCG) × 100; column "Meghalaya", Total [(A+B) or (C+D)] |
Source and method
More signals for MCV1 doses per 100 BCG doses in Meghalaya
- Meghalaya: MCV1 doses per 100 BCG doses in July 2020 was 115.5 per 100 BCG doses, above the 3-year median of 92.1 for the same month (+25%).
- Meghalaya: MCV1 doses per 100 BCG doses of 117.4 per 100 BCG doses in June 2020 is the highest in the series, which begins April 2017.
- Meghalaya: MCV1 doses per 100 BCG doses rose to 117.4 per 100 BCG doses in June 2020, against 81.5 a year earlier (+44%).
- Meghalaya: MCV1 doses per 100 BCG doses in May 2020 was 97.3 per 100 BCG doses, above the 3-year median of 79.6 for the same month (+22%).
- Meghalaya: MCV1 doses per 100 BCG doses rose to 103.8 per 100 BCG doses in March 2020, against 50.8 a year earlier (+104%).
- Meghalaya: MCV1 doses per 100 BCG doses of 103.8 per 100 BCG doses in March 2020 is the highest since May 2018.
Cite this
According to the India Health Observatory, Meghalaya: MCV1 doses per 100 BCG doses in February 2021 was 98.4 per 100 BCG doses, above the 3-year median of 33.6 for the same month (+193%). Source: Health Management Information System, Ministry of Health and Family Welfare, HMIS item-wise monthly report, All India across states, February 2021 (FY 2020-21, provisional). https://indiahealthobservatory.com/signals/mcv1-to-bcg-ratio--meghalaya--2021-02--baseline_breach
See also Meghalaya and 98.4 per 100 BCG doses in context.